{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T18:09:53Z","timestamp":1790186993486,"version":"4.1.0"},"reference-count":31,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T00:00:00Z","timestamp":1762732800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Early initiation of lipid-lowering therapy is crucial for controlling disease progression and preventing recurrent acute pancreatitis in patients with hypertriglyceridemic acute pancreatitis (HTGP). As a clinically common intervention for HTGP, blood purification enables rapid clearance of serum triglycerides. However, the current absence of a standardized outcome measurement system for blood purification in HTGP hinders systematic therapeutic evaluation by clinicians and further impedes the integration and comparison of research findings. Consequently, this study aims to develop a Core Outcome Set (COS) for blood purification in HTGP, standardizing the assessment of treatment efficacy and enhancing comparability across similar studies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The COS will be developed in accordance with the Core Outcome Measures in Effectiveness Trials (COMET) Handbook, Core Outcome Set-STAndardised Protocol (COS-STAP), Core Outcome Set-STAndards for Development (COS-STAD), and Core Outcome Set-STAndards for Reporting (COS-STAR). First, research team members and a stakeholder panel will be recruited. Outcome indicators relevant to stakeholders will be identified through systematic reviews and interviews. The stakeholder panel and domain experts will then participate in a two-round Policy Delphi process followed by a consensus meeting to discuss and score potential outcomes, ultimately determining the final COS. The finalized COS will be disseminated via a peer-reviewed publication and a checklist to facilitate implementation and promotion.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>The COS for blood purification in HTGP will establish a standardized, evidence-based outcome measurement framework. This structured approach will: (1) Enable comprehensive therapeutic evaluation by clinical teams, (2) Enhance precision in disease progression control, (3) Reduce heterogeneity across comparable studies, and may ultimately inform global treatment practices for HTGP.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Standardized registration statement<\/jats:title>\n                    <jats:p>\n                      This study has been prospectively registered with the Core Outcome Measures in Effectiveness Trials (COMET) initiative (ID: 3231; Accessible at:\n                      <jats:ext-link>https:\/\/www.comet-initiative.org\/Studies\/Details\/3231<\/jats:ext-link>\n                      ) and the China Clinical Trial Core Outcome Sets Research Center (ChiCOS) (ID: CHICOS2024000024; Accessible at:\n                      <jats:ext-link>https:\/\/www.chicos.org.cn\/home<\/jats:ext-link>\n                      ).\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmed.2025.1645585","type":"journal-article","created":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T13:30:26Z","timestamp":1762781426000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Developing a Core Outcome Set for blood purification in hypertriglyceridemic acute pancreatitis: a Delphi study protocol"],"prefix":"10.3389","volume":"12","author":[{"given":"Shengteng","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoran","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongzhen","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinghai","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinghua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,11,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1097\/MPA.0000000000000776","article-title":"A study on the etiology, severity, and mortality of 3260 patients with acute pancreatitis according to the revised atlanta classification in jiangxi, china over an 8-year period.","volume":"46","author":"Zhu","year":"2017","journal-title":"Pancreas."},{"key":"B2","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1111\/apt.12408","article-title":"The incidence of acute pancreatitis: impact of social deprivation, alcohol consumption, seasonal and demographic factors.","volume":"38","author":"Roberts","year":"2013","journal-title":"Aliment Pharmacol Ther."},{"key":"B3","doi-asserted-by":"publisher","first-page":"e0165309","DOI":"10.1371\/journal.pone.0165309","article-title":"Hungarian pancreatic study group. prospective, multicentre, nationwide clinical data from 600 cases of acute pancreatitis.","volume":"11","author":"P\u00e1rniczky","year":"2016","journal-title":"PLoS One."},{"key":"B4","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1016\/j.pan.2020.03.018","article-title":"Hungarian pancreatic study group. hypertriglyceridemia-induced acute pancreatitis: a prospective, multicenter, international cohort analysis of 716 acute pancreatitis cases.","volume":"20","author":"Mosztbacher","year":"2020","journal-title":"Pancreatology."},{"key":"B5","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1007\/s10620-021-06928-0","article-title":"Hypertriglyceridemia acute pancreatitis: animal experiment research.","volume":"67","author":"Wang","year":"2022","journal-title":"Dig Dis Sci."},{"key":"B6","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1186\/s12944-023-01968-z","article-title":"Evaluating the efficacy and timing of blood purification modalities in early-stage hyperlipidemic acute pancreatitis treatment.","volume":"22","author":"Wang","year":"2023","journal-title":"Lipids Health Dis."},{"key":"B7","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.pan.2020.06.005","article-title":"Hypertriglyceridemia and acute pancreatitis.","volume":"20","author":"Yang","year":"2020","journal-title":"Pancreatology."},{"key":"B8","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1111\/jvim.15715","article-title":"Serum triglyceride and cholesterol concentrations and lipoprotein profiles in dogs with naturally occurring pancreatitis and healthy control dogs.","volume":"34","author":"Xenoulis","year":"2020","journal-title":"J Vet Intern Med."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1038\/s41598-024-51761-w","article-title":"A single-center experience of non-bioartificial DFAPP support systems among Chinese patients with hyperlipidemic moderate\/severe acute pancreatitis.","volume":"14","author":"Cheng","year":"2024","journal-title":"Sci Rep."},{"key":"B10","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s12944-025-02448-2","article-title":"Efficacy of double filtration plasmapheresis in hyperlipidemia acute pancreatitis: a retrospective observational study.","volume":"24","author":"Qin","year":"2025","journal-title":"Lipids Health Dis."},{"key":"B11","doi-asserted-by":"publisher","first-page":"4017573","DOI":"10.1155\/2018\/4017573","article-title":"Total plasma exchange in hypertriglyceridemia-induced pancreatitis: case report and literature review.","volume":"2018","author":"Dehal","year":"2018","journal-title":"Case Rep Med."},{"key":"B12","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/s13063-019-3230-x","article-title":"COS-STAP group. Core outcome set-STAndardised protocol items: the COS-STAP statement.","volume":"20","author":"Kirkham","year":"2019","journal-title":"Trials."},{"key":"B13","doi-asserted-by":"publisher","first-page":"e1002447","DOI":"10.1371\/journal.pmed.1002447","article-title":"Core outcome set-STAndards for development: the COS-STAD recommendations.","volume":"14","author":"Kirkham","year":"2017","journal-title":"PLoS Med."},{"key":"B14","doi-asserted-by":"publisher","first-page":"e661","DOI":"10.1097\/MPA.0000000000002488","article-title":"Development and validation of the comprehensive acute pancreatitis pain core outcome set (CAPPOS): study protocol.","volume":"54","author":"Kuhlmann","year":"2025","journal-title":"Pancreas."},{"key":"B15","doi-asserted-by":"publisher","first-page":"e075859","DOI":"10.1136\/bmjopen-2023-075859","article-title":"What should be measured and reported in clinical trials for the treatment of patients with acute pancreatitis? A study protocol for establishing a core outcome set.","volume":"13","author":"Shen","year":"2023","journal-title":"BMJ Open."},{"key":"B16","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s12902-024-01562-z","article-title":"Therapeutic plasma exchange decreases serum triglyceride level rapidly and reduces early recurrence rate but no advantages in improving outcomes for patients with hyperlipidemic acute pancreatitis: a retrospective propensity score matching analysis based on twenty year\u2019s experience.","volume":"24","author":"Zheng","year":"2024","journal-title":"BMC Endocr Disord."},{"key":"B17","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1016\/j.pan.2022.07.013","article-title":"Insulin or blood purification treatment for hypertriglyceridaemia-associated acute pancreatitis: a systematic review and meta-analysis.","volume":"22","author":"He","year":"2022","journal-title":"Pancreatology."},{"key":"B18","doi-asserted-by":"publisher","first-page":"e14873","DOI":"10.1097\/MD.0000000000014873","article-title":"Continuous blood purification for severe acute pancreatitis: a systematic review and meta-analysis.","volume":"98","author":"Hu","year":"2019","journal-title":"Medicine."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1111\/aor.14016","article-title":"High-volume hemofiltration reduces short-term mortality with no influence on the incidence of MODS, hospital stay, and hospitalization cost in patients with severe-acute pancreatitis: a meta-analysis.","volume":"45","author":"Huang","year":"2021","journal-title":"Artif Organs."},{"key":"B20","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1186\/s13063-017-1978-4","article-title":"The COMET Handbook: version 1.0.","volume":"18","author":"Williamson","year":"2017","journal-title":"Trials."},{"key":"B21","doi-asserted-by":"publisher","first-page":"e1002148","DOI":"10.1371\/journal.pmed.1002148","article-title":"Core outcome set-STAndards for reporting: the COS-STAR statement.","volume":"13","author":"Kirkham","year":"2016","journal-title":"PLoS Med."},{"key":"B22","doi-asserted-by":"publisher","first-page":"3329","DOI":"10.1186\/s12889-024-20796-z","article-title":"Global, regional, and national pancreatitis burden and health inequality of pancreatitis from 1990 to 2019 with a prediction from 2020 to 2034.","volume":"24","author":"Wen","year":"2024","journal-title":"BMC Public Health."},{"key":"B23","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1001\/jamasurg.2021.0525","article-title":"SRQR and COREQ reporting guidelines for qualitative studies.","volume":"156","author":"Dossett","year":"2021","journal-title":"JAMA Surg."},{"key":"B24","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1186\/s13054-022-04113-x","article-title":"Core outcome measures for clinical effectiveness trials of nutritional and metabolic interventions in critical illness: an international modified Delphi consensus study evaluation (CONCISE).","volume":"26","author":"Davies","year":"2022","journal-title":"Crit Care."},{"key":"B25","doi-asserted-by":"publisher","first-page":"110H","DOI":"10.2471\/BLT.24.292057","article-title":"A scoping review and expert consensus on digital determinants of health.","volume":"103","author":"van Kessel","year":"2025","journal-title":"Bull World Health Organ."},{"key":"B26","doi-asserted-by":"publisher","first-page":"e1011520","DOI":"10.1371\/journal.pgen.1011520","article-title":"Investigative genetic genealogy practices warranting policy attention: results of a modified policy Delphi.","volume":"21","author":"Guerrini","year":"2025","journal-title":"PLoS Genet."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1510968","DOI":"10.3389\/fphar.2025.1510968","article-title":"Development of a core outcome set for pharmacological interventions in osteoporosis among patients with diabetes mellitus: an international consensus study protocol.","volume":"16","author":"Wei","year":"2025","journal-title":"Front Pharmacol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"102340","DOI":"10.1016\/j.eclinm.2023.102340","article-title":"Developing consensus on core outcome sets of domains for acute, the transition from acute to chronic, recurrent\/episodic, and chronic pain: results of the INTEGRATE-pain Delphi process.","volume":"66","author":"Bova","year":"2023","journal-title":"EClinicalMedicine."},{"key":"B29","doi-asserted-by":"publisher","first-page":"e090818","DOI":"10.1136\/bmjopen-2024-090818","article-title":"Developing a core outcome set for interventions in people with mild cognitive impairment: study protocol.","volume":"15","author":"Gabb","year":"2025","journal-title":"BMJ Open."},{"key":"B30","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1186\/s13063-016-1555-2","article-title":"How to select outcome measurement instruments for outcomes included in a \u201cCore Outcome Set\u201d - a practical guideline.","volume":"17","author":"Prinsen","year":"2016","journal-title":"Trials."},{"key":"B31","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s13613-020-00698-0","article-title":"Impact of prior antibiotics on infected pancreatic necrosis microbiology in ICU patients: a retrospective cohort study.","volume":"10","author":"Garret","year":"2020","journal-title":"Ann Intensive Care."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1645585\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T13:30:27Z","timestamp":1762781427000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1645585\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,10]]},"references-count":31,"alternative-id":["10.3389\/fmed.2025.1645585"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2025.1645585","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,10]]},"article-number":"1645585"}}